Gene Therapy for Lamin A/C (LMNA) Dilated Cardiomyopathy

Type: gene_therapy

Status: Investigational

Developer: MyoKardia (now Bristol Myers Squibb)

Breakthrough Summary

No summary available.

Mechanism of Action

Details pending.

Year: 2026